ID   MOSER
AC   CVCL_R731
SY   Moser; MoSer; HCT-Moser
DR   cancercelllines; CVCL_R731
DR   ColonAtlas; MOSER
DR   Cosmic; 1374636
DR   IARC_TP53; 4563
DR   Wikidata; Q54906410
RX   PubMed=3349466;
RX   PubMed=6437669;
RX   PubMed=7651727;
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Unspecified (PubMed=7651727).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
RX   PubMed=3349466;
RA   Chantret I., Barbat A., Dussaulx E., Brattain M.G., Zweibaum A.;
RT   "Epithelial polarity, villin expression, and enterocytic
RT   differentiation of cultured human colon carcinoma cells: a survey of
RT   twenty cell lines.";
RL   Cancer Res. 48:1936-1942(1988).
//
RX   PubMed=6437669; DOI=10.1007/BF00048384;
RA   Brattain M.G., Levine A.E., Chakrabarty S., Yeoman L.C.,
RA   Willson J.K.V., Long B.;
RT   "Heterogeneity of human colon carcinoma.";
RL   Cancer Metastasis Rev. 3:177-191(1984).
//
RX   PubMed=7651727;
RA   Kastrinakis W.V., Ramchurren N., Rieger K.M., Hess D.T., Loda M.,
RA   Steele G., Summerhayes I.C.;
RT   "Increased incidence of p53 mutations is associated with hepatic
RT   metastasis in colorectal neoplastic progression.";
RL   Oncogene 11:647-652(1995).
//